Medline’s long-anticipated public debut has officially marked the end of the 2025 IPO season. The private equity–backed medical supplies giant began trading on Nasdaq...
Twelve Seas Investment III, the latest special purpose acquisition company launched under the Twelve Seas franchise, has priced its U.S. IPO at $10 per...
Lumexa Imaging has priced its initial public offering at $18.50 per share, landing comfortably within its marketed range and signaling steady investor interest ahead...
ARC Group Acquisition I has revised its initial public offering plans, reducing the unit offering by 40% while rebranding and reshuffling its executive team...
SPAC Meshflow Acquisition has priced its initial public offering at $300 million, signaling a strategic move into the rapidly expanding blockchain infrastructure sector. The...